Agilent Technologies (A)

Q: What's priced into Agilent Technologies (A) stock?

The market seems to reflect a neutral valuation, with A priced cheaply compared to its peers. There is a slight expectations gap, indicating that the market may not fully anticipate the potential for continued growth.

Q: What does the Agilent Technologies (A) outlook hinge on?

The thesis hinges on maintaining revenue and EPS growth while navigating potential economic headwinds. Key factors include the performance of sector bellwethers and management's ability to avoid cutting guidance.

NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-10-15

$172.97-1.47%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Agilent Technologies’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.0%

+10% or more+5%0%−5%−10% or less

6.74 → 6.74 EPS · FY ending Oct 31, 2027 · 13 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 13 to 13; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Operational transformation via Ignite initiative	A supporting condition in Agilent Technologies's published investment case. The stated target is Sustain progress on Ignite initiative.	Intact	Ignite progress stalls or reverses in FY26	Qualitative: Strong core growth & raised guidance News confirms strong core growth, raised guidance, and margin expansion, supporting the operational transformation thesis. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Non-GAAP EPS for fiscal year 2026	Non-GAAP EPS rose from $5.58 to $6.05 guided for 2026.	Intact	EPS falls below $6.00 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Non-GAAP EPS guidance increased from approximately $5.93 in 2025-Q3 to $6.20 in 2026-Q3. Diluted EPS grew from $3.05 in 2025-Q3 to $3.55 in 2026-Q3, showing management is delivering EPS expansion consistent with stated goals. Delivery assessment Oct 15, 2026
Revenue growth for fiscal year 2026	A primary condition in Agilent Technologies's published investment case. The stated target is >= $7.39B and <= $7.49B total revenue.	Intact	Revenue falls below $7.39B in FY26	Revenue: $1.878B FY2026-Q3; GAAP. Published target: >= $7.39B and <= $7.49B total revenue. Target period is not explicitly aligned with this observation. Source published Sep 1, 20261,878,000,000 USD · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jul 31, 2026 Source: company_financial_results. Reference: 2998eddb-4c98-45a1-8abc-292a01c1e981. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Revenue guidance improved from $6.91 billion in 2025-Q2 to $7.49 billion in 2026-Q3, reflecting reported growth of 7.8% to 8.1% and core growth of 5.8% to 6.0%. Management is delivering consistent revenue growth aligned with stated targets. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-10-31 · fmp

FY2027 EPS$6.74

$6.60 → $6.74 · observed estimates

FY2027 revenue$7.99B

$7.90B → $7.99B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$6.60	$7,896,426,163	13 / 15
2026-07-25	$6.60	$7,896,426,163	13 / 15
2026-07-26	$6.60	$7,896,426,163	13 / 15
2026-07-27	$6.60	$7,896,426,163	13 / 15
2026-07-28	$6.60	$7,896,426,163	13 / 15
2026-07-29	$6.60	$7,896,426,163	13 / 15
2026-07-30	$6.60	$7,896,426,163	13 / 15
2026-07-31	$6.60	$7,896,426,163	13 / 15
2026-08-01	$6.60	$7,896,426,163	13 / 15
2026-08-02	$6.60	$7,896,426,163	13 / 15
2026-08-03	$6.60	$7,896,426,163	13 / 15
2026-08-04	$6.60	$7,896,426,163	13 / 15
2026-08-05	$6.60	$7,896,426,163	13 / 15
2026-08-06	$6.60	$7,896,426,163	13 / 15
2026-08-07	$6.60	$7,894,951,660	13 / 15
2026-08-08	$6.60	$7,894,951,660	13 / 15
2026-08-09	$6.60	$7,894,951,660	13 / 15
2026-08-10	$6.60	$7,894,951,660	13 / 15
2026-08-11	$6.60	$7,894,951,660	13 / 15
2026-08-12	$6.61	$7,899,468,890	21 / 20
2026-08-13	$6.60	$7,894,951,660	13 / 15
2026-08-14	$6.60	$7,894,951,660	13 / 15
2026-08-15	$6.60	$7,894,951,660	13 / 15
2026-08-16	$6.60	$7,894,951,660	13 / 15
2026-08-17	$6.60	$7,894,951,660	13 / 15
2026-08-18	$6.60	$7,894,951,660	13 / 15
2026-08-19	$6.60	$7,894,951,660	13 / 15
2026-08-20	$6.60	$7,894,951,660	13 / 15
2026-08-21	$6.60	$7,894,951,660	13 / 15
2026-08-22	$6.61	$7,894,951,660	12 / 15
2026-08-23	$6.61	$7,894,951,660	12 / 15
2026-08-24	$6.61	$7,894,951,660	12 / 15
2026-08-25	$6.61	$7,894,951,660	12 / 15
2026-08-26	$6.61	$7,894,951,660	13 / 15
2026-08-27	$6.61	$7,894,951,660	13 / 15
2026-08-28	$6.61	$7,894,951,660	13 / 15
2026-08-29	$6.74	$7,974,909,991	13 / 15
2026-08-30	$6.74	$7,974,909,991	13 / 15
2026-08-31	$6.74	$7,974,909,991	13 / 15
2026-09-01	$6.75	$7,983,049,037	13 / 15
2026-09-02	$6.75	$7,990,305,692	13 / 15
2026-09-03	$6.75	$7,990,303,535	13 / 15
2026-09-04	$6.75	$7,990,303,535	13 / 15
2026-09-05	$6.75	$7,990,303,535	13 / 15
2026-09-06	$6.75	$7,990,303,535	13 / 15
2026-09-07	$6.75	$7,990,303,535	13 / 15
2026-09-08	$6.75	$7,990,303,535	13 / 15
2026-09-09	$6.75	$7,990,303,535	13 / 15
2026-09-10	$6.75	$7,990,707,279	13 / 15
2026-09-11	$6.74	$7,990,707,279	13 / 16
2026-09-12	$6.74	$7,990,707,279	13 / 16
2026-09-13	$6.74	$7,990,707,279	13 / 16
2026-09-14	$6.74	$7,990,707,279	13 / 16
2026-09-15	$6.74	$7,990,707,279	13 / 16
2026-09-16	$6.74	$7,990,707,279	13 / 16
2026-09-17	$6.74	$7,990,707,279	13 / 16
2026-09-18	$6.74	$7,990,707,279	13 / 16
2026-09-19	$6.74	$7,990,707,279	13 / 16
2026-09-20	$6.74	$7,990,707,279	13 / 16
2026-09-21	$6.74	$7,990,707,279	13 / 16
2026-09-22	$6.74	$7,990,707,279	13 / 16
2026-09-23	$6.74	$7,990,707,279	13 / 16
2026-09-24	$6.74	$7,990,707,279	13 / 16
2026-09-25	$6.74	$7,990,707,279	13 / 16
2026-09-26	$6.74	$7,990,707,279	13 / 16
2026-09-27	$6.74	$7,990,707,279	13 / 16
2026-09-28	$6.74	$7,990,707,279	13 / 16
2026-09-29	$6.74	$7,990,714,232	13 / 16
2026-09-30	$6.74	$7,990,714,232	13 / 16
2026-10-01	$6.74	$7,990,714,232	13 / 15
2026-10-02	$6.75	$7,990,751,823	13 / 15
2026-10-03	$6.75	$7,990,751,823	13 / 15
2026-10-04	$6.75	$7,990,751,823	13 / 15
2026-10-05	$6.75	$7,990,751,823	13 / 15
2026-10-06	$6.75	$7,990,751,823	13 / 15
2026-10-07	$6.74	$7,986,699,192	13 / 15
2026-10-08	$6.74	$7,986,699,192	13 / 15
2026-10-09	$6.74	$7,986,274,432	13 / 15
2026-10-10	$6.74	$7,986,274,432	13 / 15
2026-10-11	$6.74	$7,986,258,732	13 / 15
2026-10-12	$6.74	$7,986,258,732	13 / 15
2026-10-13	$6.74	$7,986,258,732	13 / 15
2026-10-14	$6.74	$7,986,258,732	13 / 15
2026-10-15	$6.74	$7,986,688,698	13 / 15

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	16	4
2026-06-01	17	3
2026-07-01	17	4
2026-08-01	17	6
2026-09-01	17	7
2026-10-01	15	7

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 15 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 16–Oct 15 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Morgan StanleyOct 12

$190.00New observation · no comparable prior

BarclaysOct 7 · prior Aug 27

$175.00 → $195.00+11.4%

$0$107.25$214.50

1 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Non-GAAP EPS for fiscal year 2026Direct metric needs a verified mapping
Revenue growth for fiscal year 2026Revenue: $1.878B

Next proof point

Nov 23, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-29.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Agilent Technologies outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This is a durable compounder with a focus on consistent revenue and earnings growth. The current thesis state is stable, supported by strong recent financial performance and management's commitment to operational transformation.

What's priced into Agilent Technologies

The market seems to reflect a neutral valuation, with A priced cheaply compared to its peers. There is a slight expectations gap, indicating that the market may not fully anticipate the potential for continued growth.

What the fundamentals likely do

Fundamentals are likely to remain strong, as management is on track with revenue and EPS growth targets. However, there is a moderate risk due to the potential for economic downturns affecting the healthcare sector.

What Agilent Technologies hinges on

The thesis hinges on maintaining revenue and EPS growth while navigating potential economic headwinds. Key factors include the performance of sector bellwethers and management's ability to avoid cutting guidance.

Bottom line

Overall, A appears well-positioned for the next few years, but it must manage risks carefully. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-10-31 · fmp

FY2027 EPS$6.74

$6.60 → $6.74 · observed estimates

FY2027 revenue$7.99B

$7.90B → $7.99B · observed estimates

Exact estimates & source dates

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$6.60	$7,896,426,163	13 / 15
2026-07-25	$6.60	$7,896,426,163	13 / 15
2026-07-26	$6.60	$7,896,426,163	13 / 15
2026-07-27	$6.60	$7,896,426,163	13 / 15
2026-07-28	$6.60	$7,896,426,163	13 / 15
2026-07-29	$6.60	$7,896,426,163	13 / 15
2026-07-30	$6.60	$7,896,426,163	13 / 15
2026-07-31	$6.60	$7,896,426,163	13 / 15
2026-08-01	$6.60	$7,896,426,163	13 / 15
2026-08-02	$6.60	$7,896,426,163	13 / 15
2026-08-03	$6.60	$7,896,426,163	13 / 15
2026-08-04	$6.60	$7,896,426,163	13 / 15
2026-08-05	$6.60	$7,896,426,163	13 / 15
2026-08-06	$6.60	$7,896,426,163	13 / 15
2026-08-07	$6.60	$7,894,951,660	13 / 15
2026-08-08	$6.60	$7,894,951,660	13 / 15
2026-08-09	$6.60	$7,894,951,660	13 / 15
2026-08-10	$6.60	$7,894,951,660	13 / 15
2026-08-11	$6.60	$7,894,951,660	13 / 15
2026-08-12	$6.61	$7,899,468,890	21 / 20
2026-08-13	$6.60	$7,894,951,660	13 / 15
2026-08-14	$6.60	$7,894,951,660	13 / 15
2026-08-15	$6.60	$7,894,951,660	13 / 15
2026-08-16	$6.60	$7,894,951,660	13 / 15
2026-08-17	$6.60	$7,894,951,660	13 / 15
2026-08-18	$6.60	$7,894,951,660	13 / 15
2026-08-19	$6.60	$7,894,951,660	13 / 15
2026-08-20	$6.60	$7,894,951,660	13 / 15
2026-08-21	$6.60	$7,894,951,660	13 / 15
2026-08-22	$6.61	$7,894,951,660	12 / 15
2026-08-23	$6.61	$7,894,951,660	12 / 15
2026-08-24	$6.61	$7,894,951,660	12 / 15
2026-08-25	$6.61	$7,894,951,660	12 / 15
2026-08-26	$6.61	$7,894,951,660	13 / 15
2026-08-27	$6.61	$7,894,951,660	13 / 15
2026-08-28	$6.61	$7,894,951,660	13 / 15
2026-08-29	$6.74	$7,974,909,991	13 / 15
2026-08-30	$6.74	$7,974,909,991	13 / 15
2026-08-31	$6.74	$7,974,909,991	13 / 15
2026-09-01	$6.75	$7,983,049,037	13 / 15
2026-09-02	$6.75	$7,990,305,692	13 / 15
2026-09-03	$6.75	$7,990,303,535	13 / 15
2026-09-04	$6.75	$7,990,303,535	13 / 15
2026-09-05	$6.75	$7,990,303,535	13 / 15
2026-09-06	$6.75	$7,990,303,535	13 / 15
2026-09-07	$6.75	$7,990,303,535	13 / 15
2026-09-08	$6.75	$7,990,303,535	13 / 15
2026-09-09	$6.75	$7,990,303,535	13 / 15
2026-09-10	$6.75	$7,990,707,279	13 / 15
2026-09-11	$6.74	$7,990,707,279	13 / 16
2026-09-12	$6.74	$7,990,707,279	13 / 16
2026-09-13	$6.74	$7,990,707,279	13 / 16
2026-09-14	$6.74	$7,990,707,279	13 / 16
2026-09-15	$6.74	$7,990,707,279	13 / 16
2026-09-16	$6.74	$7,990,707,279	13 / 16
2026-09-17	$6.74	$7,990,707,279	13 / 16
2026-09-18	$6.74	$7,990,707,279	13 / 16
2026-09-19	$6.74	$7,990,707,279	13 / 16
2026-09-20	$6.74	$7,990,707,279	13 / 16
2026-09-21	$6.74	$7,990,707,279	13 / 16
2026-09-22	$6.74	$7,990,707,279	13 / 16
2026-09-23	$6.74	$7,990,707,279	13 / 16
2026-09-24	$6.74	$7,990,707,279	13 / 16
2026-09-25	$6.74	$7,990,707,279	13 / 16
2026-09-26	$6.74	$7,990,707,279	13 / 16
2026-09-27	$6.74	$7,990,707,279	13 / 16
2026-09-28	$6.74	$7,990,707,279	13 / 16
2026-09-29	$6.74	$7,990,714,232	13 / 16
2026-09-30	$6.74	$7,990,714,232	13 / 16
2026-10-01	$6.74	$7,990,714,232	13 / 15
2026-10-02	$6.75	$7,990,751,823	13 / 15
2026-10-03	$6.75	$7,990,751,823	13 / 15
2026-10-04	$6.75	$7,990,751,823	13 / 15
2026-10-05	$6.75	$7,990,751,823	13 / 15
2026-10-06	$6.75	$7,990,751,823	13 / 15
2026-10-07	$6.74	$7,986,699,192	13 / 15
2026-10-08	$6.74	$7,986,699,192	13 / 15
2026-10-09	$6.74	$7,986,274,432	13 / 15
2026-10-10	$6.74	$7,986,274,432	13 / 15
2026-10-11	$6.74	$7,986,258,732	13 / 15
2026-10-12	$6.74	$7,986,258,732	13 / 15
2026-10-13	$6.74	$7,986,258,732	13 / 15
2026-10-14	$6.74	$7,986,258,732	13 / 15
2026-10-15	$6.74	$7,986,688,698	13 / 15

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings